Key Publications


 

Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation

Swarnava Chaudhuri, Liping Li, Matthew Zimmerman, Yuemeng Chen, Yu-Xiang Chen, Melody N. Toosky, Michelle Gardner, Miaomiao Pan, Yang-Yang Li, Qingwen Kawaji, Jun-Hao Zhu, Hong-Wei Su, Amanda J. Martinot, Eric J. Rubin, Veronique Dartois* and Babak Javid*. eLife. 2018.

 

 


 

 

Latently and uninfected healthcare workers exposed to tuberculosis make protective antibodies against Mycobacterium tuberculosis

Hao Li, Xing-xing Wang, Bin Wang, Lei Fu, Guan Liu, Yu Lu, Min Cao, Hairong Huang* and Babak Javid*. PNAS. 2017.

 

 


 

 

The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity

Hong-Wei Su, Jun-Hao Zhu, Hao Li, Rong-Jun Cai, Christopher Ealand, Xun Wang, Yu-Xiang Chen, Masood ur Rehman Kayani, Ting F. Zhu, Danesh Moradigaravand, Hairong Huang, Bavesh D. Kana and Babak JavidNature Microbiology. 2016.

 

 


 

Covid-19: should the public wear face masks?

Javid B, Weekes MP, Matheson NJ. The British Medical Journal. 2020

 


 

 

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis

Watson A, Li H, Ma B, Weiss R, Bendayan D, Abramovitz L, Ben-Shalom N, Mor M, Pinko E, Bar Oz M, Wang Z, Du F, Lu Y, Rybniker J, Dahan R, Huang H, Barkan D, Xiang Y, Javid B, Freund NT. Nature Communicatations. 2021.